GERACI, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 399
EU - Europa 79
AS - Asia 44
AF - Africa 1
OC - Oceania 1
Totale 524
Nazione #
US - Stati Uniti d'America 399
SE - Svezia 37
IE - Irlanda 28
CN - Cina 13
VN - Vietnam 12
SG - Singapore 10
HK - Hong Kong 9
ES - Italia 4
IT - Italia 3
UA - Ucraina 3
DE - Germania 1
GB - Regno Unito 1
GR - Grecia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
Totale 524
Città #
Fairfield 81
Seattle 46
Cambridge 36
Ashburn 31
Houston 30
Wilmington 30
Woodbridge 30
Dublin 28
Dong Ket 12
Medford 12
Buffalo 10
Lawrence 10
Princeton 10
Beijing 9
Ann Arbor 8
Chandler 7
Norwalk 5
Barcelona 4
San Diego 4
Shanghai 4
Singapore 4
Hillsboro 3
Hong Kong 2
Auckland 1
Boardman 1
Cedar Knolls 1
Falls Church 1
Hounslow 1
Laurel 1
Redmond 1
Thessaloniki 1
Totale 424
Nome #
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: Insights from the GHOST-EU registry 80
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: A European perspective 73
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry 54
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry 54
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 50
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 50
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE v USA Registries 48
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 48
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry 46
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 32
Totale 535
Categoria #
all - tutte 2.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.111


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020162 10 7 3 12 19 23 22 21 21 8 12 4
2020/202157 4 6 2 6 4 2 2 3 6 4 4 14
2021/202270 1 3 2 2 3 3 5 7 4 3 14 23
2022/2023104 17 20 11 3 0 22 16 5 5 1 3 1
2023/202441 3 7 14 5 5 0 0 4 0 0 2 1
2024/202511 11 0 0 0 0 0 0 0 0 0 0 0
Totale 535